N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues.
Abstract |
The design, synthesis, and pharmacological evaluation of a novel class of delta opioid receptor agonists, N, N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide (6a) and its analogues, are described. These compounds, formally derived from SNC-80 (2) by replacing the piperazine ring with a piperidine ring containing an exocyclic carbon carbon double bond, were found to bind with high affinity and exhibit excellent selectivity for the delta opioid receptor as full agonists. 6a, the simplest structure in the class, exhibited an IC(50) = 0.87 nM for the delta opioid receptors and extremely high selectivity over the mu receptors (mu/delta = 4370) and the kappa receptors (kappa/delta = 8590). Rat liver microsome studies on a selected number of compounds show these olefinic piperidine compounds (6) to be considerably more stable than SNC-80. This novel series of compounds appear to interact with delta opioid receptors in a similar way to SNC-80 since they demonstrate similar SAR. Two general approaches have been established for the synthesis of these compounds, based on dehydration of benzhydryl alcohols (7) and Suzuki coupling reactions of vinyl bromide (8), and are herewith reported.
|
Authors | Z Y Wei, W Brown, B Takasaki, N Plobeck, D Delorme, F Zhou, H Yang, P Jones, L Gawell, H Gagnon, R Schmidt, S Y Yue, C Walpole, K Payza, S St-Onge, M Labarre, C Godbout, A Jakob, J Butterworth, A Kamassah, P E Morin, D Projean, J Ducharme, E Roberts |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 43
Issue 21
Pg. 3895-905
(Oct 19 2000)
ISSN: 0022-2623 [Print] United States |
PMID | 11052794
(Publication Type: Journal Article)
|
Chemical References |
- Benzamides
- N,N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide
- Piperazines
- Piperidines
- Receptors, Opioid, delta
- Receptors, Opioid, kappa
- Receptors, Opioid, mu
- 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
|
Topics |
- Administration, Oral
- Animals
- Benzamides
(chemical synthesis, chemistry, metabolism, pharmacology)
- Biological Availability
- Cell Line
- Chromatography, High Pressure Liquid
- Humans
- In Vitro Techniques
- Mass Spectrometry
- Microsomes, Liver
(metabolism)
- Models, Molecular
- Piperazines
(metabolism)
- Piperidines
(chemical synthesis, chemistry, metabolism, pharmacology)
- Radioligand Assay
- Rats
- Receptors, Opioid, delta
(agonists, metabolism)
- Receptors, Opioid, kappa
(metabolism)
- Receptors, Opioid, mu
(metabolism)
- Stereoisomerism
- Structure-Activity Relationship
- Thermodynamics
- Transfection
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|